BIOMAT Database Logo BIOMAT Database Logo

The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y12 inhibition. 2018

M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
The Cardeza Foundation for Hematologic Research and the Department of Medicine, Thomas Jefferson University, Jefferson Medical College, Philadelphia, PA, USA.

Essentials The rs773902 SNP results in differences in platelet protease-activated receptor (PAR4) function. The functional consequences of rs773902 were analyzed in human platelets and stroke patients. rs773902 affects thrombin-induced platelet function, PAR4 desensitization, stroke association. Enhanced PAR4 Thr120 effects on platelet function are blocked by ticagrelor. SUMMARY: Background F2RL3 encodes protease-activated receptor (PAR) 4 and harbors an A/G single-nucleotide polymorphism (SNP) (rs773902) with racially dimorphic allelic frequencies. This SNP mediates an alanine to threonine substitution at residue 120 that alters platelet PAR4 activation by the artificial PAR4-activation peptide (PAR4-AP) AYPGKF. Objectives To determine the functional effects of rs773902 on stimulation by a physiological agonist, thrombin, and on antiplatelet antagonist activity. Methods Healthy human donors were screened and genotyped for rs773902. Platelet function in response to thrombin was assessed without and with antiplatelet antagonists. The association of rs773902 alleles with stroke was assessed in the Stroke Genetics Network study. Results As compared with rs773902 GG donors, platelets from rs773902 AA donors had increased aggregation in response to subnanomolar concentrations of thrombin, increased granule secretion, and decreased sensitivity to PAR4 desensitization. In the presence of PAR1 blockade, this genotype effect was abolished by higher concentrations of or longer exposure to thrombin. We were unable to detect a genotype effect on thrombin-induced PAR4 cleavage, dimerization, and lipid raft localization; however, rs773902 AA platelets required a three-fold higher level of PAR4-AP for receptor desensitization. Ticagrelor, but not vorapaxar, abolished the PAR4 variant effect on thrombin-induced platelet aggregation. A significant association of modest effect was detected between the rs773902 A allele and stroke. Conclusion The F2RL3 rs773902 SNP alters platelet reactivity to thrombin; the allelic effect requires P2Y12 , and is not affected by gender. Ticagrelor blocks the enhanced reactivity of rs773902 A platelets. PAR4 encoded by the rs773902 A allele is relatively resistant to desensitization and may contribute to stroke risk.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071184 Pharmacogenomic Variants Naturally occurring genetic variations associated with drug response (e.g., dosage, extent and rate of metabolic processes). While these variants are not markers for GENETIC PREDISPOSITION TO DISEASE they influence PHARMACOKINETICS and pharmacodynamics and often occur on genes encoding drug metabolism enzymes and transporters (e.g., ANGIOTENSIN CONVERTING ENZYME; CYTOCHROME P-450 CYP2D6). Pharmacogenetic Variants,Pharmacokinetic Genetic Variants,Genetic Variant, Pharmacokinetic,Genetic Variants, Pharmacokinetic,Pharmacogenetic Variant,Pharmacogenomic Variant,Pharmacokinetic Genetic Variant,Variant, Pharmacogenetic,Variant, Pharmacogenomic,Variants, Pharmacogenetic,Variants, Pharmacogenomic

Related Publications

M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.
May 2013, Translational research : the journal of laboratory and clinical medicine,
M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking.
May 2016, Arteriosclerosis, thrombosis, and vascular biology,
M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist.
October 2001, British journal of pharmacology,
M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3.
June 2002, Thrombosis and haemostasis,
M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
The inhibition of platelet aggregation by activated macrophages is blocked by dexamethasone.
January 1993, Pharmacological research,
M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
Protease-activated receptor 4 is more important than protease-activated receptor 1 for the thrombin-induced procoagulant effect on platelets.
August 2016, Journal of thrombosis and haemostasis : JTH,
M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin.
October 2008, The Journal of biological chemistry,
M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.
September 1999, Proceedings of the National Academy of Sciences of the United States of America,
M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity.
June 2024, Journal of thrombosis and haemostasis : JTH,
M J Whitley, and D M Henke, and A Ghazi, and M Nieman, and M Stoller, and L M Simon, and E Chen, and J Vesci, and M Holinstat, and S E McKenzie, and C A Shaw, and L C Edelstein, and P F Bray
Thrombin-Induced Responses via Protease-Activated Receptor 1 Blocked by the Endothelium on Isolated Porcine Retinal Arterioles.
November 2018, Current eye research,
Copied contents to your clipboard!